Table 3.
Regulated genes in the functional categories and canonical pathways at 72 h post-TBI.
| Functional pathways | |
| Cell-to-cell signaling and interaction | Cacna1g, Kcnh1, Scn2a, Sv2b, Egr3, Cacnb4, Rgs4, Cck, Stx1a, Hrh3, Efna5, Sst, Htr1f, Ptgs2, Chrna5, Adra1b, Gabra3, Mmp9, Agt, Htr2a |
| Molecular transport | Cacna1g, Kcnh1, Clic5, Scn2a, Slc4a11, Cacnb4, Rgs4, Kcnip3, Cck, Stx1a, Hrh3, Kcnh7, Sst, Lyve1, Ptgs2, Chrna5, Gabre, Adra1b, Kcng3, Atp2b4, Agt, Htr2a |
| small molecular biochemistry | Kcnh1, Rxfp2, Cacnb4, Sstr1, Rgs4, Kcnip3, Cck, Stx1a, Pde1a, Hrh3, Acaa2, Ephb6, Gpx3, Tph1, Sst, Ptgs2, Lyve1, Chrna5, Atp2b4, Adra1b, Htr2a, Agt |
| Organismal injury and abnormalities | Cacna1l, Cacna1g, Kcnip3, Htr1f, Ptgs2, Chrna5, Gabre, Adra1b, Mmp9, Gabra3, Agt, Htr2a |
| Cell signaling | Cacna1g, Rxfp2, Cacnb4, Rgs4, Sstr1, Kcnip3, Cck, Ped1a, Hrh3, Gnat2, Sst, Htr1f, Ptgs2, Adra1b, Atp2b4, Htr2a, Agt |
| Drug metabolism | Sst, Rgs4, Lyve1, Cck, Ptgs2, Chrna5, Stx1a, Hrh3, Adra1b, Agt, Htr2a |
| Cell morphology | Efna5, Sst, Rgs4, Ptgs2, Adra1b, Mmp9, Agt |
| Cellular movement | Satb2, Sst, Rgs4, Tbr1, Ptgs2, Mmp9, Agt |
| DNA replication, recombination, and repair | Sst, Ptgs2, Ped1a, Agt |
| Nucleic acid metabolism | Ephb6, Rxfp2, Cacnb4, Sstr1, Sst, Cck, Ptgs2, Ped1a, Hrh3, Acaa2, Atp2b4, Agt |
| Canonical pathway | |
| G-protein couple receptor signaling | Rxfp2, Rgs4, Sstr1, Htr1f, Tacr3, Pde1a, Hrh3, Adra1b, Htr2a |
| Cholecystokinin/gastrin-mediated signaling | Sst, Mef2c, Cck, Ptgs2 |
| Serotonin receptor signaling | Tph1, Htr2a |
| LXR/RXR activation | Ptgs2, Mmp9, Agt |
| Gα12/13 signaling | Cdh7, Cdh12, Mef2c |
| Cytotoxic T lymphocyte-mediated apoptosis of target cells | Hla-Dq1a, RT1-M6-1/Rt1-M6-2 |
| GABA receptor signaling | Gabre, Gabra3 |
| c-AMP-mediated signaling | Rgs4, Htr1f, Pde1a, Hrh3 |
| OX40 signaling pathway | Hla-Dq1a, RT1-M6-1/Rt1-MG-2 |
| AMPK signaling | Pfkp, Chrna5, Adra1b |